Skip to main content

General

The FDA Asks Bayer To Submit Problems Linked With Essure

Categories: General

Last week, the U.S. Food and Drug Administration (FDA) issued a letter to Bayer indicating requirements for submitting adverse event reports and postmarket activities associated with

Risperdal Plaintiffs Allowed To Claim Punitive Damages

Categories: General

Defendants named in the Risperdal gynecomastia litigation, Johnson & Johnson, and its Janssen Pharmaceuticals subsidiary, will now have to compensate thousands of Risperdal…

Philadelphia too, proves to be unlucky for Xarelto Plaintiff

Categories: General

Just when Xarelto plaintiff attorneys were rejoicing and preparing on the lines of the first Philadelphia Xarelto trial which brought in the first-ever win for the…

An Appeal Submitted To Retain a $72 Million Talcum Verdict

Categories: General

The Johnson & Johnson’s Talcum powder case in which the verdict of $72 million was dismissed in October 2017 was put forth for an appeal by the family of the plaintiff, an Alabama woman who developed ovarian cancer due to the long-term use of…

MCL Status Requested For Abilify Cases Filed in New Jersey

Categories: General

A request has been put before the New Jersey Supreme Court by both parties of Abilify litigation for the creation of a Multicounty Litigation (MCL) to ensure that future…

Despite Its First TRT Trial Win, Auxilium Opts To Settle

Categories: General

Despite winning its first trial in November 2017, Testim gel makers, Auxilium, settled a lawsuit for an undisclosed amount, just days before the trial in Pennsylvania’s Philadelphia Court of Common Pleas. Allegations put forth by the…

No Ban On Transvaginal Mesh Devices So Far By FDA

Categories: General

The FDA has shown no signs or indications regarding any ban on transvaginal mesh devices used to treat pelvic organ prolapse (POP) and stress urinary…

Xarelto Makers’ Hopes Squashed A Second Time

Categories: General

Portola Pharmaceuticals received news of a second-time delay from the U.S. Food & Drug Administration (FDA) regarding the approval of AndexXa, an antidote developed to monitor uncontrollable bleeding linked to Xarelto and Eliquis.…

Eli Lilly Announces A Global Settlement For All TRT Lawsuits

Categories: General

Eli Lilly and Company, the maker of Axiron used in the treatment of low testosterone levels is one of the defendants in the over 6,000 centralized

St. Louis Court Rules In Favor Of Bayer In An Essure Lawsuit

Categories: General

Bayer received good news beginning of the year as the Missouri Supreme Court ruled in its favor regarding an Essure Lawsuit filed by 92 women for injuries allegedly caused…